Related references
Note: Only part of the references are listed.Data Resource Profile: National Cancer Registration Dataset in England
Katherine E. Henson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013-2014
Katherine E. Henson et al.
BRITISH JOURNAL OF CANCER (2018)
Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: An analysis of national audit data
Gavin S. Jones et al.
EUROPEAN JOURNAL OF CANCER (2018)
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
Michael Wallington et al.
LANCET ONCOLOGY (2016)
Avoidability of hospital deaths and association with hospital-wide mortality ratios: retrospective case record review and regression analysis
Helen Hogan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Avoidability of hospital deaths and association with hospital-wide mortality ratios: retrospective case record review and regression analysis
Helen Hogan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
C. M. Booth et al.
BRITISH JOURNAL OF CANCER (2014)
Patient Income Level and Cancer Clinical Trial Participation
Joseph M. Unger et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets
L. Elliss-Brookes et al.
BRITISH JOURNAL OF CANCER (2012)
The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
Saroj Niraula et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
Bostjan Seruga et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
FE van Leeuwen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
